- Home
- SHEL vs NVS Comparison
SHEL vs NVS Comparison
Compare SHEL & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHEL
- NVS
- Stock Information
- Founded
- SHEL 1907
- NVS 1895
- Country
- SHEL United Kingdom
- NVS Switzerland
- Employees
- SHEL N/A
- NVS N/A
- Industry
- SHEL Oil & Gas Production
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- SHEL Energy
- NVS Health Care
- Exchange
- SHEL Nasdaq
- NVS Nasdaq
- Market Cap
- SHEL 199.9B
- NVS 230.5B
- IPO Year
- SHEL N/A
- NVS 1991
- Fundamental
- Price
- SHEL $60.63
- NVS $97.08
- Analyst Decision
- SHEL Buy
- NVS Hold
- Analyst Count
- SHEL 5
- NVS 6
- Target Price
- SHEL $79.50
- NVS $121.25
- AVG Volume (30 Days)
- SHEL 4.1M
- NVS 1.1M
- Earning Date
- SHEL 01-30-2025
- NVS 01-31-2025
- Dividend Yield
- SHEL 4.54%
- NVS 3.89%
- EPS Growth
- SHEL N/A
- NVS 130.53
- EPS
- SHEL 2.42
- NVS 8.58
- Revenue
- SHEL $296,762,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- SHEL $4.86
- NVS $10.04
- Revenue Next Year
- SHEL N/A
- NVS $4.55
- P/E Ratio
- SHEL $11.96
- NVS $11.02
- Revenue Growth
- SHEL N/A
- NVS 8.92
- 52 Week Low
- SHEL $60.15
- NVS $92.35
- 52 Week High
- SHEL $74.61
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- SHEL 28.28
- NVS 27.93
- Support Level
- SHEL $60.53
- NVS $97.69
- Resistance Level
- SHEL $62.29
- NVS $99.67
- Average True Range (ATR)
- SHEL 0.93
- NVS 1.01
- MACD
- SHEL -0.33
- NVS -0.18
- Stochastic Oscillator
- SHEL 8.74
- NVS 10.97
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.5 million barrels of liquids and 7.3 billion cubic feet of natural gas per day. At end-2023, reserves stood at 9.6 billion barrels of oil equivalent, 49% of which, consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.6 mmb/d located in the Americas, Asia, Africa, and Europe and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.